Dr. Peter Morcos, MD

Dr. Morcos practices at Scripps Clinic la Jolla ASC in La Jolla, California.

Dr. Morcos' NPI, 1922207430, was assigned on July 13, 2007. Dr. Morcos graduated from University Of Washington School Of Medicine in 2007. Dr. Morcos holds California license A114501.

Dr. Morcos' primary practice is Scripps Clinic la Jolla ASC, at 9898 Genesee Avenue, La Jolla, CA 92037. The practice phone is (414) 975-3807.

Dr. Morcos' primary practice is Scripps Clinic la Jolla ASC in La Jolla, California. Dr. Morcos is also affiliated with Scripps Memorial Hospital La Jolla. The medical group on file is Scripps Clinic Medical Group. Dmand AI also links Dr. Morcos to 2 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Morcos practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Morcos' primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Morcos is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Morcos' licenses on file in 2 states: California and Washington.

Dmand AI lists aneurysm, aortic atherosclerois, atrial fibrillation and flutter, cardiac arrhythmia, cardiomyopathy, cerebrovascular disease, chest pain and chronic embolism thrombosis among the conditions Dr. Morcos treats.

CMS data shows 5,521 Medicare services from Dr. Morcos across 29 procedure codes in 2024, for 2,772 Medicare patients. Medicare paid $268,425 for them.

CMS counts 2,772 Medicare patients who saw Dr. Morcos in 2024. The largest group is 75 to 84, with 1,170 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Morcos' median patient age at 62, with 50% women.

In 2024, Dr. Morcos wrote 2,769 Medicare Part D claims for 442 patients. 78% of them were for generic drugs. CMS names the drug for 2,575 of them, across 36 drugs with 11 or more claims each, at $689,492 in total drug cost. In 2023, CMS named 2,534 claims across 41 drugs.

Dr. Morcos accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Morcos as offering telehealth.

Dmand AI links 16 papers to Dr. Morcos, published from 2008 to 2019. 2013 was the busiest year, with 3. The most frequent topics are Carbazoles, Cyclopropanes and Isoindoles. Dr. Morcos has published most often in Cancer Chemother Pharmacol. Dr. Morcos' most frequent co-authors are Sai-Hong I I. Ou, MD, Nancy Sarah Shulman, MD and Shirish Madhav Gadgeel, MD.

CMS Open Payments shows 415 general payments to Dr. Morcos from 44 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,247.

Dr. Morcos graduated from University Of Washington School Of Medicine in 2007. Dr. Morcos is a member of ACC.

Dr. Morcos is in network with 9 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.